Novartis International AG (NVS) Says EU Approves Inflammatory Disease Drug  
10/28/2009 8:27:25 AM

Reuters -- The European Union has approved Novartis AG's Ilaris to treat children and adults with a rare but potentially fatal inflammatory disease, the Swiss drugmaker said on Wednesday. Novartis said in a statement the accelerated EU decision follows approvals in the United States and Switzerland.